Healthcare Sector

MRK

Market Tracker

$89.34
+1.66
(+1.89%)
7:00 pm
Next Earnings: (est.) 08/01/23 12:00 am
  • MRK (Selected)

    Merck & Co., Inc.
  • MRK#

    Merck & Co., Inc. (MRK
  • MRKR

    Marker Therapeutics, Inc.

MRK Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

MRK Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

MRK Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

MRK Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

MRK Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

MRK Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
04/04/2025 CALL $90.00 3,016 +2,995 +14,261.90%
07/18/2025 PUT $85.00 4,424 +1,014 +29.74%
03/28/2025 CALL $94.00 763 +752 +6,836.36%
10/17/2025 PUT $80.00 700 +700
02/21/2025 CALL $87.00 4,525 +675 +17.53%
09/19/2025 PUT $70.00 1,389 +675 +94.54%
02/21/2025 CALL $89.00 1,604 -318 -16.55%
03/28/2025 CALL $89.00 56,201 -452 -0.80%
03/21/2025 CALL $85.00 3,277 -529 -13.90%
06/20/2025 CALL $90.00 1,991 -581 -22.59%
03/21/2025 CALL $90.00 10,682 -650 -5.74%
04/17/2025 CALL $90.00 19,777 -718 -3.50%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

MRK Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.04% 77.07M 8.28B
Vanguard 500 Index Fund 2.31% 58.61M 6.3B
Fidelity 500 Index Fund 1.09% 27.79M 2.99B
SPDR S&P 500 ETF Trust 1.08% 27.45M 2.95B
iShares Core S&P 500 ETF 0.89% 22.63M 2.43B
Vanguard Index-Value Index Fund 0.86% 21.91M 2.35B
Select Sector SPDR Fund-Health Care 0.81% 20.59M 2.21B
Vanguard Specialized-Health Care Fund 0.72% 18.31M 1.97B
Vanguard Institutional Index Fund-Institutional Index Fund 0.70% 17.77M 1.91B
Schwab Strategic Tr-Schwab U.S. Dividend Equity ETF 0.68% 17.38M 1.87B

MRK News

  • MERCK INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MRK

    02/22 06:15 pm

    GlobeNewswire Inc.

    Read more
  • Hyperlipidemia Drugs Market Size to Promote USD 31.49 Bn by 2034

    02/21 11:00 am

    GlobeNewswire Inc.

    Read more
  • ROSEN, SKILLED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK

    02/20 05:50 pm

    GlobeNewswire Inc.

    Read more
  • BESREMi Achieves Strong Market Growth Amid Rising Demand for Polycythemia Vera Treatment

    02/20 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Antibody-Drug Conjugates Market to Witness Rapid Growth Across 7MM During the Study Period (2020–2034) as New Innovations Drive Therapy Advancements | DelveInsight

    02/20 02:00 pm

    GlobeNewswire Inc.

    Read more
  • North America Leads the Beta-Glucan Boom: Market Insights & Industry Innovations

    02/19 09:45 pm

    GlobeNewswire Inc.

    Read more
  • MERCK & CO., INC. (NYSE: MRK) INVESTOR ALERT: Investors With Large Losses in Merck & Co., Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

    02/19 02:50 pm

    GlobeNewswire Inc.

    Read more
  • Merck & Co. Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Filed Against MRK

    02/18 09:09 pm

    GlobeNewswire Inc.

    Read more
  • Global Immune Checkpoint Inhibitors Market to Cross USD 100 Billion by 2032 | DelveInsight

    02/18 02:00 pm

    GlobeNewswire Inc.

    Read more
  • 3 Blue-Chip Dividend Stocks Trading at Multiyear Lows

    02/13 10:30 am

    The Motley Fool

    Read more
  • Respiratory Syncytial Virus Therapeutics Market to Hit USD 4.64 Billion by 2032, Growing at a 14.5% CAGR – SNS Insider

    02/13 10:00 am

    GlobeNewswire Inc.

    Read more
  • Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.

    02/13 07:35 am

    The Motley Fool

    Read more
  • MRK INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead the Merck Class Action Lawsuit

    02/12 07:31 pm

    GlobeNewswire Inc.

    Read more
  • SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Merck & Co., Inc. Securities and Sets a Lead Plaintiff Deadline of April 14, 2025

    02/12 06:00 pm

    GlobeNewswire Inc.

    Read more
  • Gilead Sciences Beats Q4 EPS Forecast

    02/11 05:40 pm

    The Motley Fool

    Read more
  • Neuroregeneration Therapy Market to Surpass USD 64.8 Billion by 2034, Driven by Advancements in Regenerative Medicine and Rising Neurological Disorders | Transparency Market Research

    02/11 04:48 am

    GlobeNewswire Inc.

    Read more
  • 2 Stocks That Could Soar Again in 2025

    02/08 09:50 am

    The Motley Fool

    Read more
  • Paresthesia Treatment Market Outlook: USD 8.0 Billion by 2034, Growing with an Aging Population and Rising Healthcare Expenditures | Analysis by TMR

    02/07 12:39 pm

    GlobeNewswire Inc.

    Read more
  • Aplastic Anemia Global Clinical Trials Review 2024 | Now Available

    02/04 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Recombinant Chemicals Market to Reach US$ 6.7 Bn by 2034, Driven by Rising Demand for Protein-Based Vaccines & Genetic Disorder Treatments – TMR Analysis

    01/31 10:00 am

    GlobeNewswire Inc.

    Read more
  • Up More Than 500% in 12 Months, Is It Too Late to Buy Summit Therapeutics Stock?

    01/30 10:15 am

    The Motley Fool

    Read more
  • Single Use Assemblies Market Global Forecasts to 2029: Rapid Growth in Single-Use Assemblies Market Driven by Biologics and Biosimilars Demand

    01/29 11:57 am

    GlobeNewswire Inc.

    Read more
  • Potential Revolution in Healthcare Brewing, Powered by AI Innovation

    01/29 09:04 am

    Benzinga

    Read more
  • Alopecia Treatment Market Size to Surpass USD 5.20 Billion by 2033 | Straits Research

    01/27 11:55 am

    GlobeNewswire Inc.

    Read more
  • Biological Drugs Strategic Research Report 2024-2030, Profiles of 45+ Players Including Abbott Laboratories, Amgen, Baxter, Biogen, BMS, Eli Lilly and Co, GSK, Merck, Novartis, and Pfizer

    01/27 11:49 am

    GlobeNewswire Inc.

    Read more
  • Why This Beaten-Down Stock Is a Buy in 2025 and Beyond

    01/27 09:45 am

    The Motley Fool

    Read more
  • Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It.

    01/25 08:45 am

    The Motley Fool

    Read more
  • These Were the 5 Worst-Performing Stocks in the Dow Jones Industrial Average in 2024

    01/25 07:17 am

    The Motley Fool

    Read more
  • Live Cell Imaging Market Report 2025, with Competitor Profiles of Top 10+ Major Market Players

    01/24 05:57 am

    GlobeNewswire Inc.

    Read more
  • Can the 8 Worst-Performing Dow Jones Stocks in 2024 Beat the S&P 500 in 2025?

    01/21 06:34 am

    The Motley Fool

    Read more
  • Is Moderna Stock a Buy?

    01/19 05:55 am

    The Motley Fool

    Read more
  • This Vanguard ETF Has 23% of Its Portfolio Invested in Tech Stocks, but It Can Still Help You Generate Decades of Passive Income

    01/17 09:45 am

    The Motley Fool

    Read more
  • 7MM Type 1 Diabetes Market Drug Forecast and Market Analysis 2023-2024 & 2033: Value to Reach $9.91 Billion - Synergistic Rise of Pumps, CGMs, and Ultra-rapid-acting Insulins in T1D Management

    01/17 05:53 am

    GlobeNewswire Inc.

    Read more
  • Global Pharma & Biotech CRM Software Market To Surpass Valuation of US$ 20.0 Billion by 2033 | Astute Analytica

    01/17 04:30 am

    GlobeNewswire Inc.

    Read more
  • 3 Magnificent S&P 500 Dividend Stocks Down 25%, 60%, and 26% to Buy and Hold Forever

    01/16 04:55 am

    The Motley Fool

    Read more
  • Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight

    01/14 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Nicotine Replacement Therapies Market Forecast to Reach $7.52 Billion by 2032: Growing Shift Towards Personalised Nicotine Replacement Therapies

    01/10 06:58 am

    GlobeNewswire Inc.

    Read more
  • Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference

    01/09 03:12 pm

    Benzinga

    Read more
  • NUT Midline Carcinoma Treatment Market Research Report 2023-2024 & 2034: Market Forecast by Treatment, Route of Administration, and End-User Across 5 Regions and 17+ Countries

    01/09 11:53 am

    GlobeNewswire Inc.

    Read more
  • Moderna Shares Spike on H5N1 News—What’s Next for Investors?

    01/09 08:14 am

    Investing.com

    Read more
  • Global Poly (N-vinyl formamide) market to Worth Over US$ 633.85 Million By 2033 | Astute Analytica

    01/09 04:30 am

    GlobeNewswire Inc.

    Read more
  • United States Chromatography Resin Market Competition, Forecast and Opportunities, 2029F Featuring Key Players, GE Healthcare, Merck, Thermo Fisher Scientific, Pall, and Purolite

    01/03 10:50 am

    GlobeNewswire Inc.

    Read more
  • UK Approves Merck's Hypertension Drug Acquired Via $11 Billion Acceleron Pharma Deal

    01/02 12:15 pm

    Benzinga

    Read more
  • 2 High-Yield Dividend Stocks to Buy Early in 2025

    12/31 08:45 am

    The Motley Fool

    Read more
  • Revolutionizing Pharma: The Impact of Big Data and Technological Advances on the Pharma Industry

    12/31 06:52 am

    GlobeNewswire Inc.

    Read more
  • 5 Undervalued Stocks Positioned for a Breakout Year in 2025

    12/30 09:30 am

    Investing.com

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: